A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema

NCT05642312 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

245

Enrollment

INDUSTRY

Sponsor class

Conditions

Uveitic Macular Edema

Interventions

DRUG: Vamikibart
OTHER: Sham

Sponsor

Hoffmann-La Roche